| P50 | author | William M. McMahon | Q115588962 |
| P2093 | author name string | Thayne L Sweeten | |
| | Robert S Fujinami | |
| | Nancy K Burgess | |
| P2860 | cites work | Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine | Q24316480 |
| | Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database | Q24530178 |
| | Functional requirement for class I MHC in CNS development and plasticity | Q24669537 |
| | Enterocolitis in children with developmental disorders | Q28139701 |
| | Infantile autism: a genetic study of 21 twin pairs | Q28254263 |
| | Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region | Q28297391 |
| | Synthesis of serotonin by a second tryptophan hydroxylase isoform | Q28513857 |
| | Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child | Q30449648 |
| | Role of serotonin in the immune system and in neuroimmune interactions | Q33542079 |
| | Gastrointestinal abnormalities in children with autistic disorder | Q33878978 |
| | The amygdala and related structures in the pathophysiology of autism | Q34519323 |
| | Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder | Q35851031 |
| | Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis | Q36299093 |
| | Serotonin Initiation of Delayed-Type Hypersensitivity: Mediation by a Primitive Thy-1<sup>+</sup> Antigen-Specific Clone or by Specific Monoclonal IgE Antibody | Q36539748 |
| | Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation | Q39116195 |
| | Depressed lymphocyte responsiveness in autistic children | Q39807754 |
| | Autistic symptoms in a child with congenital cytomegaloviras infection | Q40140492 |
| | Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses | Q40372215 |
| | Increased Prevalence of Familial Autoimmunity in Probands With Pervasive Developmental Disorders | Q40547096 |
| | 5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation | Q40926803 |
| | A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells | Q41325249 |
| | Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study | Q41350182 |
| | Autism and the immune system | Q41540888 |
| | Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis | Q42438513 |
| | Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder | Q42483254 |
| | A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders | Q42540933 |
| | Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone | Q42551219 |
| | Autism in children with congenital rubella | Q43582958 |
| | Evidence for an association with the serotonin transporter promoter region polymorphism and autism | Q43621858 |
| | Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate | Q43839654 |
| | Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism | Q43938271 |
| | Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia | Q44137042 |
| | Hyperserotoninemia and antiserotonin antibodies in autism and other disorders | Q44432395 |
| | Lower cortisol and higher ACTH levels in individuals with autism | Q44575661 |
| | Autism and autoimmune disease: A family study | Q44586796 |
| | Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples | Q44675829 |
| | Mechanisms of serotonin-induced lymphocyte proliferation inhibition | Q44770141 |
| | Hyperserotonemia and amine metabolites in autistic and retarded children | Q44889143 |
| | Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates | Q44929697 |
| | Evidence of brain overgrowth in the first year of life in autism | Q44996531 |
| | Influence of serotonin on lymphokine secretion in vitro | Q46728129 |
| | Intestinal cytokines in children with pervasive developmental disorders | Q47704406 |
| | Intravenous immunoglobulin treatment of children with autism | Q47767730 |
| | Prevalence of serum antibodies to caudate nucleus in autistic children | Q48091807 |
| | Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders | Q48220936 |
| | Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children | Q48266971 |
| | Antibodies to Myelin Basic Protein in Children with Autistic Behavior | Q48329357 |
| | Neuropathology of infantile autism | Q48418627 |
| | Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid | Q48501754 |
| | Influence of serotonin on the immune response | Q48517217 |
| | Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys | Q48614774 |
| | Childhood psychosis and monoamine metabolites in spinal fluid | Q48712415 |
| | Serotonin transporter (5-HTT) gene variants associated with autism? | Q50302129 |
| | Evidence of linkage between the serotonin transporter and autistic disorder | Q50302505 |
| | Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation | Q50302638 |
| | Serotonin and autism: biochemical and molecular biology features | Q50302909 |
| | A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder | Q50302925 |
| | Effects of tryptophan depletion in drug-free adults with autistic disorder | Q50302929 |
| | Lymphocyte subsets and interleukin-2 receptors in autistic children | Q50303329 |
| | Elevated serotonin levels in autism: association with the major histocompatibility complex | Q50303403 |
| | DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein | Q50303968 |
| | Lymphocyte function in autism and Rett syndrome | Q50304650 |
| | Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects | Q50305081 |
| | Possible association of the extended MHC haplotype B44-SC30-DR4 with autism | Q50305793 |
| | Platelet 5-HT2 serotonin receptor binding sites in autistic children and their first-degree relatives | Q50306124 |
| | Binding of [3H]serotonin to lymphocytes in patients with neuropsychiatric disorders | Q50306493 |
| | Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence | Q50306873 |
| | Brief report: autistic disorder in three children with cytomegalovirus infection | Q50307013 |
| | Free serotonin in plasma: autistic children and their first-degree relatives | Q50307639 |
| | Whole blood serotonin in autistic and normal subjects | Q50308120 |
| | Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects | Q50308259 |
| | Reduced natural killer cell activity in autism | Q50308336 |
| | The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder | Q50309735 |
| | 5-HTTLPR variants not associated with autistic spectrum disorders | Q50311920 |
| | Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder | Q50313176 |
| | Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium | Q50313598 |
| | Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children | Q50313624 |
| | Exclusion of linkage to the HLA region in ninety multiplex sibships with autism | Q50313763 |
| | Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism | Q50313816 |
| | Immune abnormalities in patients with autism | Q50342000 |
| | Serotonin relationships of autistic probands and their first-degree relatives | Q50343704 |
| | Modulation of chicken plaque-forming cells by serotonin and dopamine | Q67966017 |
| | Alteration of NK- and ADCC-activities in rats genetically selected for low or high platelet serotonin level | Q68091540 |
| | Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes | Q68214212 |
| | Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors | Q68413296 |
| | Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists | Q68963634 |
| | Role of serotonin in the regulation of human natural killer cell cytotoxicity | Q68996802 |
| | Specific uptake of serotonin by murine macrophages | Q69026265 |
| | The role of mast cells in the elicitation of experimental allergic encephalomyelitis | Q69054510 |
| | Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and allogeneic cells | Q70183935 |
| | Role of serotonin in the regulation of interferon-gamma production by human natural killer cells | Q70615539 |
| | Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity | Q71384558 |
| | Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo | Q72037658 |
| | Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin | Q72724330 |
| | Influence of antidepressants on mitogen stimulation of human lymphocytes | Q84790039 |
| | Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons | Q95825852 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| P304 | page(s) | 697-704 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Journal of Autism and Developmental Disorders | Q6294817 |
| P1476 | title | Hyperserotoninemia and altered immunity in autism | |
| P478 | volume | 36 | |